Skip to main content
. 2020 Dec 23;8(2):e001689. doi: 10.1136/jitc-2020-001689

Figure 4.

Figure 4

Prognostic value of soluble CD73 in patients with metastatic melanoma. A, Kaplan-Meier curves estimate overall survival of all patients receiving nivolumab or pembrolizumab or (B) nivolumab plus ipilimumab according to baseline serum activity of CD73. CD73 high (red line) is >38.8 pmol/min/mg protein and CD73 low is <38.8 pmol/min/mg protein (blue line). P values were calculated using the log-rank test.